NEWH
NewHydrogen, Inc.0.0158
+0.0002+0.96%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
11.96MP/E (TTM)
-Basic EPS (TTM)
0.00Dividend Yield
0%Recent Filings
10-Q
10-Q
Q2 FY2025 results
NewHydrogen's Q2 FY2025 results show no revenue, with operating expenses climbing 42% y/y to $623,832, driven by higher research and development costs up 66% y/y to $147,867 from outside fees and consultants, while selling and marketing rose 34% y/y to $94,092. Net loss widened 42% y/y to $623,704, matching the operating loss as other income dipped to $128; stock-based compensation of $116,527 for the half-year explains the non-cash drag. Cash burned $1.0M in operations for the six months, leaving $1.1M on hand with working capital of $1.15M, bolstered by a May equity line for up to $3M and post-quarter draws netting $462K. Adjusted EBITDA, reconciled in the 10-Q, stood at $(1.1M) for the half, excluding $1.6K depreciation. Expenses are mounting. Yet R&D momentum builds toward green hydrogen breakthroughs.
10-Q
Q1 FY2025 results
NewHydrogen posted a Q1 FY2025 net loss of $476,094, up slightly from $471,004 a year earlier, driven by higher selling and marketing expenses of $106,479 (up $31,508 y/y) and research and development at $101,518 (up $12,579 y/y), offset by lower general and administrative costs. No revenue yet, but cash burn moderated to $492,812 from operations, leaving $1.6M in cash after a $492,812 q/q drop. Operating loss matched net loss closely, with minimal interest income of $177. Stock compensation added $55,376 to expenses. Liquidity covers nine months, bolstered by a May 2025 equity line for up to $3M. Yet competition in green hydrogen tech looms large.
8-K
NewHydrogen secures $3M equity line
NewHydrogen inked an equity financing pact with GHS Investments on May 2, 2025, unlocking up to $3 million in funding through put options on its common stock, priced at a 7.5% discount to recent lows. The deal issued 803,536 commitment shares upfront, capping GHS's ownership at 4.99% to curb dilution while fueling general corporate needs. Funding rolls out over 24 months post-S-1 effectiveness. Yet dilution looms large if shares flood the market.
10-K
FY2024 results
NewHydrogen posted a narrowed net loss of $3.2 million for FY2024 ended December 31, 2024, down sharply from $12.1 million in 2023, thanks to slashed non-cash stock compensation while ramping R&D into its ThermoLoop green hydrogen tech at UC Santa Barbara. Expenses climbed in selling and marketing to $317K and R&D to $363K, yet G&A dropped to $1.1 million, reflecting tighter controls amid zero revenue as a development-stage player. Q4 wrapped with $2.1 million in working capital, buoyed by no investing or financing outflows, but cash burn hit $1.6 million yearly from ops. No quarterly breakdowns disclosed. Liquidity holds for 12 months, but scaling prototyping looms in 2026. Going concern doubts persist without fresh capital.
IPO
Website
Employees
Sector
Industry
BW
Babcock & Wilcox Enterprises, I
5.28-0.25
BWEN
Broadwind, Inc.
3.21-0.25
CETY
Clean Energy Technologies, Inc.
0.98+0.03
CGEH
Capstone Green Energy Holdings
5.00-0.75
HNOI
HNO International Inc.
0.42+0.00
HYOR
Hyorc Corporation
0.03+0.00
HYSR
SunHydrogen Inc.
0.03+0.00
NGHI
New Green Hemp Inc.
0.30+0.00
NNE
Nano Nuclear Energy Inc.
32.31+0.96
NPWR
NET Power Inc.
2.52+0.04